Login to Your Account

BIO-Europe 2011

Staying Positive in the Gloom; European Biotechs Muddle Through Despite Lack of VC

By Cormac Sheridan
BioWorld International Correspondent

Wednesday, November 9, 2011
DUSSELDORF, Germany – BIO-Europe Fall 2011 entered its final day as Europe's financial system teetered on the brink – yet again – following Greece's shock decision to put its recently agreed bailout package to a popular vote. Although the issues facing Europe's biotechnology industry seem pretty minor in comparison, a definite sense of gloom has pervaded many of the discussions here at BIO-Europe.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription